Yinghui Jane Huang United States Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate Yinghui J. Huang1,2,3, Shin Foong Ngiow1,2,3, Amy E. Baxter1,2, Sasikanth Manne1,2, Simone L. Park1,2, Jennifer E. Wu1,2,3, Omar Khan1,2, Josephine R. Giles1,2,3, E. John Wherry1,2,3 1Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania; [...]
Taras V. Zadvornyi Ukraine EXPRESSION OF COLLAGEN DENSITY-REGULATORY FACTORS IN PROSTATE CANCER Zadvornyi T., Mushii O., Pavlova A., Burda T., Shevchuk A., Kashuba E., Lukianova N. R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the National Academy of Sciences of Ukraine, Kyiv, Ukraine Abstract Background The growth of malignant neoplasms, including prostate [...]
Alzhraa Ali Mohamed Turkey Meropenem-ZnO-Nps combination against CRKP biofilms, with lower nephrotoxicity Alzhraa Ali Mohamed1,2,*, Safaa Saed1, Sara Ramadan El-Sayed1, Mohamed Taha Yassin3, Mohamed Gad4, Eman Tartour1, Hoda A. Fathey1, Asmaa S Taha1, Asmaa H. Mohamed1, Fatimah Olyan Al-Otibi2, Mohamed Ragab Ab-delGawwad5, Mohamed M. Sayed Ahmed1, Susan Ahmed Almalki6, Mohamed Abdel?Haleem1,* 1 Microbiology and [...]
Bolaji Olawale Nigeria Leveraging Computational approaches in identifying Novel HER-2+ Breast Cancer Potential Therapeutics: Integrating Virtual Screening and MD Simulation Olawale Quadri Bolajia 1,9, Temitope Isaac Adelusi2,9, Taiwo Ooreoluwa Ojo3,9, Ibrahim Damilare Boyenle4, Abdul-Quddus Kehinde Oyedele5, Taiwo Temitope Ogunjobi6, Adegboye Oyewole Oyaronbi6, Sukurat Oluwatoyin Ayoola7, Abdeen Tunde Ogunlana8,9 1. National Institute for Pharmaceutical Research [...]
Cristina Papuc Moldova Lipidogram status in pacients with RA Papuc Cristina1 , Elena Deseatnicova1,2 1 Department of Rheumatology and Nephrology, Nicolae Testemi?anu State University of Medicine and Pharmacy, Chi?in?u, Republic of Moldova 2 Laboratory of Immunology, Nicolae Testemi?anu State University of Medicine and Pharmacy, Chi?in?u, Republic of Moldova Abstract Background Background. Rheumatoid arthritis (RA) [...]
DAUD MARIAM OMOWUNMI Nigeria COMPUTATIONAL MODELLING DESIGN OF NOVEL NMDAR AGONIST FOR THE TREATMENT OF SCHIZOPHRENIA Mariam Omowunmi Daud1 Amena Khatun Manica2, Michael Olanrewaju Faloyo3, Afuape Raphael Akinwunmi4 Aminat Motunrayo Adekunle5, Aminat Adedolapo Adekola2, Ilyas Adisa Lawal6, Musiliyu Ayofe Salawu7, Jamiu Adewole Muritala8, Ridwan Olajire Muraina2, Rukayat Abiodun Hassan5, Sherif Olabisi Ogunyemi5 1Department of [...]
KAOUTAR BEN MAKHLOUF Morocco Impact of Clinical and Biological Factors on Intra-Cytoplasmic Sperm Injection (ICSI) Success Rates: A Retrospective Analysis of 478 Infertile Couples Kaoutar BEN MAKHLOUF 1, 2, Yousra BENMAKHLOUF 1, Najib BOUDRA 2, Yasmina SERGHINI 2, Naima GHAILANI NOUROUTI 1, Amina BARAKAT 1, Mohcine BENNANI MECHITA 1 1 Department of Biology, Intelligent [...]
Asmita Bharti India Identifying potential metabolic proteins and their cross-talk in neurodegenerative disorders via genomic and proteomic approach Bharti A and Bubber P Biochemistry Discipline, Indira Gandhi National Open University, New Delhi-110068, India Abstract Background Neurodegeneration is a pathological condition involving progressive loss of neuronal cells in the brain. These conditions usually develop gradually [...]
Gabriela Stînca Moldova Laboratory Biomarkers of Multiple Sclerosis Diagnosis Gabriela Stinca1, Victoria Simon2 1. Nicolae Testemi?anu State University of Medicine and Pharmacy, Chi?in?u, Republic of Moldova 2. Department of Neurology No.1, Nicolae Testemi?anu State University of Medicine and Pharmacy, Chi?in?u, Republic of Moldova Abstract Background Multiple sclerosis (MS) is a chronic neuroinflammatory disease characterized [...]
Leandra Nascimento Fonseca Brazil CAR-T Cell Therapy Applied to Onco-Hematology and Probable Adverse Effects 1- Leandra Nascimento Fonseca (lfonsecabiomed@gmail.com)1 1. Undergraduate student of Biomedicine at Cesumar University, participant in PVIC/ICETI-UniCesumar and the GEPIS Research Group. Abstract Background The treatment of hematologic and lymphatic cancers, due to the proliferative dynamics of the disease, represents a [...]